Document |
Document Title |
WO/2023/216674A1 |
Provided are a method for preparing a heavy metal passivation material, and a porous biological calcium carbonate-based passivation material with urease activity acquired by means of the method. Based on some specific components, the pas...
|
WO/2023/216227A1 |
Provided are a method for preparing a microbial microcapsule and a method for synthesizing a microbial flora (particularly a cross-species microbial flora). According to the principle that chitosan and sodium tripolyphosphate are subject...
|
WO/2023/220501A1 |
Disclosed herein are fusion protein, comprising (a) at least one XI domain comprising a. half-life extension compound, including but not limited, to a half-life extension polypeptide; (b) at least one X2 domain comprising an anionic bloc...
|
WO/2023/217776A1 |
The present invention relates to methods of aseptically producing filamentous fungi in a bioreactor by pseudo-solid state fermentation. The present invention further relates to methods of continuously, aseptically producing filamentous f...
|
WO/2023/217911A1 |
The present invention relates to a genetically modified fungal microorganism for producing glycosidases (EC 3.2.1) in the presence of a simple carbon source as well as to a method for producing glycosidases (EC 3.2.1).
|
WO/2023/218898A1 |
The present invention provides: lactic acid bacteria that enhance IL-12p70 and IFN-λ production, thereby making it possible to increases resistance against infection by infectious microorganisms and viruses, relieve stress, and suppress...
|
WO/2023/218226A1 |
The present invention relates to a method for growing a biomaterial (7) directly onto a substrate (5) using a floating rafting system (1) over a liquid culturing medium (6) for incubating said biomaterial (7) preventing the need of lamin...
|
WO/2023/216685A1 |
The present invention belongs to the technical field of bioengineering. Provided are a strain for synthesizing 2'-fucosyllactose by taking glucose as a carbon source, a construction method therefor, and use thereof. The strain is obtaine...
|
WO/2023/219120A1 |
The present invention addresses the problem of providing an anti-CD37/anti-CD3 bispecific antibody that can be used in treatment of humans. The present inventors created multiple anti-CD3scFvs having improved stability and varying affi...
|
WO/2023/219160A1 |
The present invention provides a protein having an adjuvant activity of potentiating cellular immunity. More specifically, provided is an adjuvant composition for potentiating cellular immunity, said composition containing a protein havi...
|
WO/2023/219458A1 |
The present invention relates to a method of reducing carbon dioxide using microalgae. The carbon dioxide reduction method according to the present invention comprises the steps of: supplying carbon dioxide (CO2)to a first medium within ...
|
WO/2023/217056A1 |
The present invention belongs to the technical field of environmental microorganisms, and in particular, provides a composite microbial deodorant, a method for preparing same, and use thereof. The composite microbial deodorant comprises ...
|
WO/2023/218130A1 |
Disclosed is a method of producing a fungal biomass (200). The method comprises culturing (202) genetically changed genomes of filamentous fungus (204) on a medium, which comprises non-metabolizable glucose analogue (206) and a growth ca...
|
WO/2023/220728A2 |
The present disclosure relates, in part, to microbial hosts capable of synthesizing cis-3-hexenol, cis-3-hexenal, trans-3-hexenol, trans-3-hexenal, trans-2-hexenal, cis-2- hexenal and related compounds from hexanoic acid and methods for ...
|
WO/2023/220060A1 |
The disclosure relates to novel methods, compositions, and genetically modified microorganisms for extracting and/or isolating bioproducts from microorganisms having recalcitrant cell walls. In some aspects, the disclosure relates to sol...
|
WO/2023/216907A1 |
The present invention relates to the technical field of biology, in particular to a 5'UTR fragment, a biological material, a method for shortening the length of a main stem of a cucurbitaceous plant, and a related product. The 5'UTR frag...
|
WO/2023/218197A1 |
The present invention relates to biopesticides and their use in crop protection. In particular the present invention relates to modified Paraburkholderia cells comprising a heterologous biosynthetic gene cluster for producing an antimicr...
|
WO/2023/219482A1 |
The invention relates to: an isolated strain of Bacillus thuringiensis var israelensis (RVP BTI-20), deposited with access number CM-CNRG TB193, which exhibits bactericidal activity; a mixture comprising an isolated strain of Bacillus th...
|
WO/2023/216565A1 |
Provided are a biological flocculant, a preparation method therefor, and use thereof in blue-green algae treatment. The biological flocculant comprises cationic hydroxyethyl cellulose and an extracellular polysaccharide. The extracellula...
|
WO/2023/220281A1 |
The present disclosure provides feed additive compositions and related methods for the treatment and prevention of coinfection with Clostridium bacteria and Eimeria protozoa. The feed additive compositions herein can include a microbial ...
|
WO/2023/219300A1 |
The present invention relates to: a Chlorella vulgaris strain deposited with accession number KCTC14768BP; a cosmetic composition, a quasi-drug composition and a food composition for skin improvement, all of which comprise any one or mor...
|
WO/2023/219121A1 |
The present invention addresses the problem of providing an anti-TAA/anti-CD3 multispecific antibody that can be used in treatment of humans. In order to produce an anti-TAA/anti-CD3 multispecific antibody that targets various tumor as...
|
WO/2023/214419A1 |
The present invention composed of product is one of the most significant products for sustainable agriculture; it is a low cost valuable biotechnological product. It adds organic matter in the soil which builds up soil fertility, leads t...
|
WO/2023/214632A1 |
The present invention relates to a composition for crosslinking artificial leather based on a mycelium mat, comprising tannic acid (TA), or a method for manufacturing a mycelium mat into leather by using same. Specifically, the method fo...
|
WO/2023/214868A1 |
The invention relates to an isolated strain of Metarhizium anisopliae (RVP MA-20), deposited with accession number CM-CNRG TB195, which exhibits insecticidal activity; a mixture comprising the isolated strain of Metarhizium anisopliae (R...
|
WO/2023/214867A1 |
The invention relates to an isolated strain of Beauveria bassiana (RVP BB-20), deposited with accession number CM-CNRG TB196, which exhibits insecticidal activity; a mixture comprising the isolated strain of Beauveria bassiana (RVP BB-20...
|
WO/2023/215502A1 |
Provided is a method for producing mycelium protein powder from upcycled water feedstocks, such as waste feedstocks from food or beverage processes. Also provided is mycelium protein powder. Further provided is a food product comprising ...
|
WO/2023/213016A1 |
Provided are a genetically engineered bacterium for producing catharanthine by fermentation, and use thereof. The catharanthine is produced by fermenting microorganisms with a simple carbon source as a substrate, thereby realizing the de...
|
WO/2023/215813A1 |
Orally-deliverable programmable bacteria cells that colonize colorectal tumors and produce diagnostic and therapeutic molecules, as well as related compositions and methods.
|
WO/2023/214841A1 |
This application relates to a novel grain tempeh, a method for preparing grain tempeh, grain tempeh prepared thereby, and a fermented and aged grain tempeh. The present application provides a method for preparing grain tempeh, comprising...
|
WO/2023/214592A1 |
The present invention provides a fertilizer for agricultural products that has a high nitrogen content. The present invention provides a fertilizer for agricultural products that contains a crushed product of a marine red photosynthetic ...
|
WO/2023/214869A1 |
The present invention relates to an isolated strain of Bacillus thuringiensis var. kurstaki (RVP BTK-20), deposited with accession number CM-CNRG TB194 and exhibiting bactericidal activity. The invention further relates to a mixture comp...
|
WO/2023/215798A1 |
Disclosed here are bacteriophage compositions for Escherichia comprising CRISPR-Cas systems and methods of use thereof.
|
WO/2023/214798A1 |
The present invention relates to a method for effectively carrying out a crosslinking reaction when manufacturing a leather material using mushroom mycelium which is an eco-friendly material capable of substituting for animal leather and...
|
WO/2023/214579A1 |
The present disclosure provides the production of a plasmid for a virus-derived structure. In one aspect, the present disclosure provides a plasmid that codes for at least some elements of a virus-derived structure. In one embodiment, th...
|
WO/2023/215488A1 |
Provided is a method for fermenting upcycled water feedstocks, such as waste feedstocks from food or beverage processes. Since feedstock is a major cost driver for most fermentation processes, use of waste feedstocks can meaningfully low...
|
WO/2023/215800A1 |
Synthetic genetic platforms in eukaryote cells (such as yeast) is described. A representative synthetic genetic platform includes a eukaryote cell genetically modified to express an auxin receptor, an auxin response factor, and a reporte...
|
WO/2023/215399A1 |
The disclosure provides for methods of constructing synthetic chromosomes including the steps of providing host cells with an endogenous chromosome, transforming a cloning vector and a cloning cassette into the host cells, excising targe...
|
WO/2023/214840A1 |
The present application pertains to a tempeh preparation method suitable for mass production, tempeh prepared thereby, and aged fermentate of tempeh. The present application provides a method for preparation of tempeh, the method compris...
|
WO/2023/156217A9 |
The subject of the present invention are microorganisms with reduced competence and compositions containing such microorganisms, in particular feed, food and pharmaceutical compositions.
|
WO/2023/210755A1 |
The purpose of the present invention is to provide a method for screening for a useful microorganism, whereby it becomes possible to obtain a useful microorganism with high efficiency. Provided is a method for screening for a useful mi...
|
WO/2023/210916A1 |
The present invention relates to a swine feed additive, comprising a composite fermentation product made up of Bacillus spp. strains and prebiotics, for promoting growth or improving meat quality. The feed additive of the present inventi...
|
WO/2023/210244A1 |
A protein according to the present invention is a protein which is disclosed in any one among [1]-[3], and which has nicotinamide phosphoribosyltransferase activity. [1] A protein comprising an amino acid sequence represented by SEQ ID N...
|
WO/2023/208223A1 |
Provided are Megasphaera sp. strains preserved in Guangdong Microbial Culture Collection Center, with preservation numbers of GDMCC No: 62001, GDMCC No: 62000, and GDMCC No: 61999, respectively. 16S rRNAs of the strains are set forth in ...
|
WO/2023/209736A1 |
A method for production of biogas comprising methane with or without hydrogen wherein said method comprises treating a lignocellulosic substrate of reduced particle size with a microbial consortium in an anaerobic digester at a temperatu...
|
WO/2023/208225A1 |
Provided are Megasphaera sp. strains preserved in Guangdong Microbial Culture Collection Center, with preservation numbers of GDMCC No: 62001, GDMCC No: 62000, and GDMCC No: 61999, respectively. 16S rRNAs of the strains are set forth in ...
|
WO/2023/209237A1 |
The present invention relates to selected strains of Lactiplantibacillus plantarum and compositions containing the strains for promoting the growth of physiological microbiota and preventing dysbiosis, infections and inflammatory disease...
|
WO/2023/208146A1 |
Provided are a method and carrier for the biosynthesis of ergothioneine. The method comprises: introducing into a host cell at least one nucleic acid construct of a polynucleotide sequence comprising: a coding glutamylcysteine synthetase...
|
WO/2023/207887A1 |
Provided are Bacillus subtilis ZF-1 and use thereof in inhibiting African swine fever virus (ASFV). A Bacillus subtilis strain having an inhibiting effect on ASFV was selected by screening from 95 strains, the accession number of the str...
|
WO/2023/208762A2 |
A mutant yeast cell, comprising : (i) a first genetic modification for expression of a NAD+ dependent protein that functions in a first metabolic pathway converting a sugar alcohol into a fermentation product; and (ii) a second genetic m...
|